Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001104659-26-112060

Chief Legal Officer sold 14,051 shares at $36.57 ($513,845)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Sullivan Mark · Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-25 Sale : show line 1 in the form 10b5-1 −14,051 $36.57 $513,845 494,228 D
Open-market sales · 14,051 sh · avg $36.57 · $513,845
Loading xslF345X06/tm2626627-2_4seq1.xml…